The Role of Sleep in Protecting Spatial Memories From Age-Related Decline
Healthy aging is characterized by impaired spatial memory compared to younger adults. These impairments not only negatively impact quality of life but are also an early marker for the onset of dementia, especially Alzheimer's Disease. While sleep plays an active role in spatial memory consolidation in young adults, the extent to which sleep contributes to this process in aged adults is yet to be determined. The objective of this developmental R21 project is to determine the impact of sleep on spatial memory in cognitively healthy, aged adults, and evaluate the potential for a sleep intervention targeting memory reactivation to improve performance in this population. The project will include a single experiment using an ecologically valid ambulatory virtual environment to test the effects of sleep on spatial memory performance in aged adults.
Aim 1 will determine whether post-learning sleep benefits spatial memory in aged adults, more so than a period of wakefulness. Spatial memory performance will be measured using well-established tasks in a virtual environment, before and after a 90-minute delay consisting of either an EEG-monitored nap or wakefulness. Changes in performance between these two conditions will be measured after the 90-minute delay and again one week later. The key hypothesis for this aim is that post-learning sleep will improve spatial memory recall more than an equivalent period of wakefulness, and that this improvement will correlate with sleep stages and EEG waveforms that are linked with memory consolidation.
Aim 2 will test whether targeted memory reactivation, a technique used to bias memory consolidation by obtrusively presenting sounds during sleep, can be used to enhance spatial memory in aged adults. To this end, task-related sounds will be presented to participants during a nap immediately after learning and during nocturnal sleep over the following week. Spatial memory performance will be compared between this group and a sleep group for which no sounds will be presented during sleep. The key hypotheses are that this manipulation will improve spatial memory performance, and that these behavioral effects will be mediated by memory-related EEG waveforms elicited by sounds presented during sleep.
By combining sleep, high-density electrophysiology, and a realistic testing environment, this project will determine the benefit of sleep on spatial memory in aged adults and test ways to leverage sleep to make consolidation more efficient. Results will inform our understanding of sleep-dependent consolidation in aged adults and pave the way for scalable, non-invasive treatments to improve day-to-day life and provide critical protections against dementia.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Eitan Schechtman-Drayman
- Phone Number: 847-722-9220
- Email: eitans@uci.edu
Study Contact Backup
- Name: Elizabeth Chrastil
- Email: chrastil@uci.edu
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion:
- Age >=60.
- Montreal Cognitive Assessment score above 25.
- Good general health with no disease or conditions expected to interfere with the study.
- Fluent in English.
- Fully ambulatory without the use of a cane, walker, or wheelchair.
- Believe they will be able to fall asleep in a lab setting for an afternoon nap.
Exclusion:
- No history or current diagnosis of psychiatric disorders.
- No history or current neurological disease.
- No current sleep disorder, including sleep apnea and insomnia.
- No snoring during sleep.
- No uncorrected hearing, visual or motor impairment.
- No changes in medication usage over the past month and no plans to make such changes over the course of the study.
All inclusion/exclusion criteria, except for the Montreal Cognitive Assessment, will be based on self-report.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Wake group
Participants watch a feature-length film ("Stand By Me") in the study room for 90 minutes. They are instructed to remain awake and alert throughout. The experimenter monitors wakefulness from the control room via a baby monitor and a real-time EEG display. If EEG signs of non-rapid-eye-movement-sleep (NREM) Stage 1 or deeper sleep onset are observed, the participant is prompted to remain awake. |
|
|
Active Comparator: Sleep group
Participants are given a 90-minute nap opportunity in a darkened sleep room (bed, clean linens, blanket) with low-volume white noise delivered via earphones. EEG (electroencephalography) with EOG (electrooculography) and EMG (electromyography) is recorded continuously. During NREM sleep, auditory cues that are unrelated to the virtual reality (VR) task are delivered. Once the experimenter confirms via real-time EEG that the participant is in NREM Stage 2 or Stage 3 sleep, non-task-associated auditory cues are delivered via a speaker at a volume calibrated individually during a Sound Volume Test before the nap - the lowest volume at which the participant can reliably detect the sound while awake. Following the nap, participants may shower or wash up in a private room with a sink. |
This group will be allowed to sleep shortly after learning. |
|
Experimental: Sleep+TargetedMemoryReactivation (TMR) Group
Participants follow the same nap protocol as the Sleep group, except that task-relevant sounds are presented during sleep. A minimum of 6 successful cue presentations during the nap is required for inclusion in TMR-specific analyses. |
This group will be allowed to sleep shortly after learning. The researchers will unobtrusively and repeatedly present a sound that was linked with a spatial task during sleep. This method was shown to improve memory in various tasks. The sounds will be presented both in the lab and at home. In both cases, the sounds will be presented during non-REM sleep stages 2 and 3. The sounds will only be presented to the Sleep+TMR group (N = 42). |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance on spatial memory task - wayfinding task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
Accuracy will be measured (percent of correct trials) |
Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
|
Performance on spatial memory task - pointing task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
Angular error will be measured (averaged over trials) |
Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance on other memory tasks - paired-associates task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
The researchers will use the paired-associates task to examine the effects of sleep on declarative memories. Percent correct pairs will be used. |
Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
|
Performance on other memory tasks - serial reaction time task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
The researchers will use the serial reaction time task to examine the effects of sleep on non-declarative memories. The number of correct sequences will be used. |
Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 7502
- R21AG101676 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All datasets that can be shared will be deposited in OpenNeuro, which is an NIH-supported free and open platform for validating and sharing data. De-identified behavioral data, task programs and code, analysis code, experimental protocols, and any additional metadata will be stored and shared on the Open Science Framework. Additional code will be available on GitHub.
IPD Sharing Time Frame
Shared data generated from this project will be made available as soon as possible, and no later than the time of publication or the end of the funding period, whichever comes first. The duration of preservation and sharing of the data will be a minimum of 10 years after the end of the funding period.
IPD Sharing Access Criteria
There are no anticipated factors or limitations that will affect the access, distribution or reuse of the scientific data generated by the proposal.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.